SETTING: Hospital in-patients with suspected tuberculous meningitis (TBM), predominantly in India. OBJECTIVE: To determine whether interferon-gamma (IFN-gamma) secreting Mycobacterium tuberculosis antigen-specific T-cells are present in the cerebrospinal fluid (CSF) of patients with TBM and to evaluate the feasibility of CSF enzyme-linked immunospot (ELISpot) for the diagnosis of active TBM. DESIGN: Prospective blinded hospital-based study. RESULTS: The overnight ELISpot assay detected M. tuberculosis antigen-specific IFN-gamma secreting T-cells in CSF from nine of 10 prospectively recruited patients with TBM, and zero of seven control patients with meningitis of other aetiology. This corresponds to a diagnostic sensitivity of 90% (95%CI 56-100) and specificity of 100% (95%CI 59-100). CONCLUSION: This pilot study demonstrates proof-of-principle for a new T-cell-based diagnostic test for TBM which is rapid, sensitive and specific.
SETTING: Hospital in-patients with suspected tuberculous meningitis (TBM), predominantly in India. OBJECTIVE: To determine whether interferon-gamma (IFN-gamma) secreting Mycobacterium tuberculosis antigen-specific T-cells are present in the cerebrospinal fluid (CSF) of patients with TBM and to evaluate the feasibility of CSF enzyme-linked immunospot (ELISpot) for the diagnosis of active TBM. DESIGN: Prospective blinded hospital-based study. RESULTS: The overnight ELISpot assay detected M. tuberculosis antigen-specific IFN-gamma secreting T-cells in CSF from nine of 10 prospectively recruited patients with TBM, and zero of seven control patients with meningitis of other aetiology. This corresponds to a diagnostic sensitivity of 90% (95%CI 56-100) and specificity of 100% (95%CI 59-100). CONCLUSION: This pilot study demonstrates proof-of-principle for a new T-cell-based diagnostic test for TBM which is rapid, sensitive and specific.
Authors: Madhukar Pai; Laura L Flores; Nitika Pai; Alan Hubbard; Lee W Riley; John M Colford Journal: Lancet Infect Dis Date: 2003-10 Impact factor: 25.071
Authors: G E Thwaites; T T H Chau; K Stepniewska; N H Phu; L V Chuong; D X Sinh; N J White; C M Parry; J J Farrar Journal: Lancet Date: 2002-10-26 Impact factor: 79.321
Authors: Claudia Jafari; Martin Ernst; Barbara Kalsdorf; Ulf Greinert; Roland Diel; Detlef Kirsten; Kathleen Marienfeld; Ajit Lalvani; Christoph Lange Journal: Am J Respir Crit Care Med Date: 2006-07-20 Impact factor: 21.405
Authors: A Lalvani; A A Pathan; H McShane; R J Wilkinson; M Latif; C P Conlon; G Pasvol; A V Hill Journal: Am J Respir Crit Care Med Date: 2001-03 Impact factor: 21.405
Authors: R S Kashyap; R P Kainthla; R M Satpute; N H Chandak; H J Purohit; G M Taori; H F Daginawala Journal: Neurol India Date: 2004-09 Impact factor: 2.117
Authors: Ann L N Chapman; Mwansa Munkanta; Katalin A Wilkinson; Ansar A Pathan; Katie Ewer; Helen Ayles; William H Reece; Alwyn Mwinga; Peter Godfrey-Faussett; Ajit Lalvani Journal: AIDS Date: 2002-11-22 Impact factor: 4.177
Authors: Jacqueline M Achkar; Stephen D Lawn; Mahomed-Yunus S Moosa; Colleen A Wright; Victoria O Kasprowicz Journal: J Infect Dis Date: 2011-11-15 Impact factor: 5.226
Authors: K Kösters; R Nau; A Bossink; I Greiffendorf; M Jentsch; M Ernst; S Thijsen; T Hinks; A Lalvani; C Lange Journal: Infection Date: 2008-01-12 Impact factor: 3.553